Aspira Women's Health Inc. AWHL
0.26
0.00
0.00%
as of 25 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow AWHL
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 201.29% | 327.14% | 269.20% | 314.66% |
+8 more TTM periods Free account |
|
| (213.58%) | (173.69%) | (233.49%) | (179.16%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
423.40% | 578.50% | (1,981.40%) | (646.65%) | |
Average Days of Receivables |
63.42 | 58.37 | 47.80 | 51.48 | |
Free Cash Flow per Share |
(0.11) | (0.10) | (0.21) | (0.17) | |
Free Cash Flow |
(4.73) | (4.29) | (7.05) | (6.09) | |
Capital Expenditures |
(0.17) | — | (0.02) | (0.02) | |
Piotroski F-Score |
1.00 | 2.00 | 5.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
94.39% | 241.87% | 206.31% | (759.57%) | |
Accounts Receivable Turnover |
6.19 | 7.06 | 8.39 | 7.26 | |
Accounts Payable Turnover |
1.57 | 2.03 | 1.94 | 1.55 | |
Inventory Turnover |
13.98 | 12.60 | 11.34 | 11.79 | |
Average Days of Payables |
285.22 | 206.53 | 136.78 | 196.09 | |
Days of Inventory on Hand |
23.93 | 30.64 | 28.31 | 30.53 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
36.50% | 35.16% | 31.23% | 31.23% | |
Selling, General and Administrative Expense of Revenue |
103.03% | 103.00% | 118.82% | 140.41% | |
Share Based Compensation of Revenue |
5.53% | 5.28% | 5.76% | 8.41% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.46 | 0.42 | 0.55 | 0.56 | |
Depreciation/Fixed assets |
0.94 | 3.66 | 2.38 | 2.00 | |
Capex/Depreciation |
(0.99) | 0.00 | (0.16) | (0.28) | |
Revenue per Share |
0.19 | 0.20 | 0.27 | 0.26 | |
Operating CF per Share |
(0.10) | (0.10) | (0.21) | (0.17) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(117.07%) | (115.13%) | (138.67%) | (115.66%) |
Columns are period end dates